BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1835129)

  • 1. Orchidectomy or LHRH-analogue? Which do the patients prefer and what treatment would Norwegian urologists prefer if they had advanced cancer of the prostate?
    Samdal F; Vada K; Lundmo PI; Mjølnerød OK
    Scand J Urol Nephrol; 1991; 25(3):197-9. PubMed ID: 1835129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential preservation of bone mineralisation by LHRH agonists in the treatment of metastatic prostate cancer.
    Clarke NW; McClure J; George NJ
    Eur Urol; 1991; 19(2):114-7. PubMed ID: 1827070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between surgical orchidectomy and the LHRH agonist 'Zoladex' (ICI 188630) in the treatment of metastatic cancer of the prostate.
    Peeling WB
    Prog Clin Biol Res; 1989; 303():41-5. PubMed ID: 2528738
    [No Abstract]   [Full Text] [Related]  

  • 4. Luteinising hormone-releasing hormone analogues alone in the treatment of advanced disease.
    Debruyne F
    Horm Res; 1989; 32 Suppl 1():62-4; discussion 64-5. PubMed ID: 2533157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U.K. trials of treatment for M1 prostatic cancer. The LH-RH analogue Zoladex vs. orchidectomy.
    Ryan PG; Peeling WB
    Am J Clin Oncol; 1988; 11 Suppl 2():S169-72. PubMed ID: 2977272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary hyperplasia after goserelin (LHRH-analogue) therapy.
    Radner H; Pummer K; Lax S; Wandschneider G; Höfler H
    Neuropathol Appl Neurobiol; 1991 Feb; 17(1):75-81. PubMed ID: 1647501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between surgical orchidectomy and LH-RH analogue ('Zoladex', ICI 118,630) in the treatment of advanced prostatic carcinoma--a multi-centre clinical study.
    Kaisary AV; Ryan PG; Turkes A; Peeling WB; Griffiths K
    Prog Clin Biol Res; 1988; 260():89-100. PubMed ID: 2966408
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy of prostatic cancer.
    Huben RP; Perrapato SD
    Drugs Aging; 1991; 1(5):353-63. PubMed ID: 1838950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
    Allen JM; Williams G; O'Shea JP; Smith C; Yeo T; Kerle D; Bloom SR
    Urol Res; 1984; 12(5):249-51. PubMed ID: 6240150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular histology after treatment with LH-RH analogue for carcinoma of the prostate.
    Johansen TE; Ogreid P; Kjellevold K; Blom P
    Br J Urol; 1990 Apr; 65(4):376-8. PubMed ID: 2140282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
    Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
    Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with an LHRH analogue in the management of relapsed progressive prostatic cancer.
    Kerle D; Williams G; Ware H; Doble A; Allen J; Bloom SR
    Br J Urol; 1984 Oct; 56(5):495-8. PubMed ID: 6242022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
    Bouffioux C
    Eur Urol; 1988; 15(3-4):187-92. PubMed ID: 2975222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical or surgical orchidectomy: the patients' choice.
    Chadwick DJ; Gillatt DA; Gingell JC
    BMJ; 1991 Mar; 302(6776):572. PubMed ID: 1827036
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies].
    Kuber W; Treu T; Kratzik C; Girsch E; Zeillinger R; Spona J
    Wien Klin Wochenschr; 1990 Nov; 102(21):640-7. PubMed ID: 2148044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogues of LHRH versus orchidectomy: comparison of economic costs for castration in advanced prostate cancer.
    Rutqvist LE; Wilking N
    Br J Cancer; 1992 Jun; 65(6):927-9. PubMed ID: 1616866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orchiectomy and buserelin in combination with flutamide: comparative results in metastatic prostatic carcinoma].
    Mora MJ; Extramiana J; Paniagua P; González P; Mañas A; Pérez MJ; Navarro J; Arrizabalaga M
    Actas Urol Esp; 1991; 15(6):548-52. PubMed ID: 1792994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LHRH analogues in combination with an anti-androgen in the treatment of advanced disease.
    Denis L
    Horm Res; 1989; 32 Suppl 1():66-7; discussion 68. PubMed ID: 2533158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.
    Hjertberg H; Varenhorst E; Svensson M; Kågedal B; Nordenskjöld B
    Acta Oncol; 1988; 27(4):361-4. PubMed ID: 2974290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma. A. V. Kaisary et al. Br. J. Urol., 67, 502-508, 1991.
    Bunce C
    Br J Urol; 1992 Apr; 69(4):441-2. PubMed ID: 1533812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.